U.S., Nov. 11 -- ClinicalTrials.gov registry received information related to the study (NCT07226362) titled 'A Study Evaluating the Safety, Tolerability and Pharmacokinetics of ASY202 in Healthy Adults' on Oct. 28.
Brief Summary: A Phase 1 clinical trial to evaluate the pharmacokinetics, relative bioavailability, safety and tolerability of DHE inhalation powder delivered by dry powder inhaler, DHE IV, and DHE nasal spray.
Study Start Date: June 09
Study Type: INTERVENTIONAL
Condition:
Safety, and Tolerability
Intervention:
COMBINATION_PRODUCT: DHE inhalation powder low dose administered via dry powder inhaler (DPI) device
The DHE inhalation powder is a pre-metered drug-device combination product containing DHE dry powder low dose fo...